Device Trial Radar · NCT06285695
Clareon Toric Study (T2-T9)
Last checked: Nov 20, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
129
Actual
Start
Apr 10, 2024
Primary completion
Jun 25, 2026
Study completion Jun 25, 2026
Sponsor
- Lead sponsor
- Alcon ResearchNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 29, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this post-market study is to describe the long-term safety and performance of Clareon Toric Intraocular Lenses (IOLs).
Conditions
- Aphakia
- Corneal Astigmatism
Interventions
Clareon Toric IOLDevice
Aspheric hydrophobic acrylic IOL placed in the capsular bag in the posterior chamber of the eye during cataract surgery for the visual correction of aphakia and preexisting corneal astigmatism
Cataract surgeryProcedure
Cataract extraction by phacoemulsification, followed by implantation with a Clareon Toric IOL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean monocular best corrected distance visual acuity (BCDVA)Time frame: Month 6, Year 1
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Gimbel Eye Centre
Calgary, Alberta, Canada
Uptown Eye Specialists
Concord, Ontario, Canada
Prism Eye Institute
Oakville, Ontario, Canada
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.